e-learning
resources
Stockholm 2007
Monday 17.09.2007
Therapy of thoracic malignancies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pathway of lung cancer presentation – does it affect management?
K. Lilley, D. Saralaya, D. Newton, A. Dwarakanath, R. Mustafa, B. Jacob (Bradford, United Kingdom)
Source:
Annual Congress 2007 - Therapy of thoracic malignancies
Session:
Therapy of thoracic malignancies
Session type:
Thematic Poster Session
Number:
2554
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Lilley, D. Saralaya, D. Newton, A. Dwarakanath, R. Mustafa, B. Jacob (Bradford, United Kingdom). Pathway of lung cancer presentation – does it affect management?. Eur Respir J 2007; 30: Suppl. 51, 2554
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Delay in the management of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 322s
Year: 2005
How should PET influence the management of lung cancer?
Source: Annual Congress 2013 –ME11 How should PET influence the management of lung cancer?
Year: 2013
Complexity of diagnostics of complicated lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004
Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007
Delays in lung cancer management
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
Reducing delays in lung cancer diagnostic pathways to improve patient experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Milestones in the management of lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Locally advanced and metastatic lung cancer management delay: Tunisian department experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Poor performance status patient in advanced lung cancer: to treat or not to treat?
Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat?
Year: 2008
Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway
Source: International Congress 2018 – The many facets of respiratory nursing
Year: 2018
Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006
Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
Panel discussion: Improving the pathway of lung cancer patients, can we do it better?
Source: ERS webinar 2021: Panel discussion on improving the pathway of lung cancer patients, can we do it better?
Year: 2021
Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy?
Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician
Year: 2010
Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept